Abstract
To clarify the possible mechanism of cigarette smoke (CS)-induced pulmonary hypertension and furthermore provide effective targets for prevention and treatment, the effects of chronic CS on rat pulmonary arterial smooth muscle in vivo and nicotine treatment on rat pulmonary arterial smooth muscle cells (PASMCs) in vitro were investigated. In this study, we demonstrated that chronic CS exposure led to rat weight loss, right ventricular hypertrophy, and pulmonary arterial remodeling. A fluorescence microscope was used to measure intracellular calcium concentration ([Ca2+]i) in rat distal PASMCs. Results showed that basal [Ca2+]i and store-operated calcium entry (SOCE) levels in PASMCs from 3- and 6-mo CS-exposed rats were markedly higher than those in cells from the unexposed control animals (the increases in 6-mo CS group were more significant than that in 3-mo group), accompanied with increased canonical transient receptor potential 1 (TRPC1) and TRPC6 expression at both mRNA and protein levels in isolated distal PA. Simultaneously, in vitro study showed that nicotine treatment (10 nM) significantly increased basal [Ca2+]i and SOCE and upregulated TRPC1 and TRPC6 expression in cultured rat distal PASMCs. TRPC siRNA knockdown strategies revealed that the elevations of basal [Ca2+]i and SOCE induced by nicotine in PASMCs were TRPC1 and TRPC6 dependent. These results suggested that chronic CS-induced changes in vascular tone and structure in PA and the development of pulmonary hypertension might be largely due to upregulation of TRPC1 and TRPC6 expression in PASMCs, in which nicotine played an important role.
Keywords: cigarette smoke, pulmonary hypertension, TRPC, SOCE
pulmonary hypertension (PH) is characterized by a persistent and gradual increase of pulmonary arterial pressure, leading to right ventricular hypertrophy, and right ventricular failure, ultimately leading to death (1). PH is an important complication of chronic obstructive pulmonary disease (COPD) and also an independent risk factor that affects the course of COPD. Recent studies showed that up to 70% of patients with COPD suffer from at least mild PH (16). Cigarette smoke (CS) has been indicated as one of the main causes of COPD and PH; studies on smokers with mild COPD demonstrated that 25% of these patients had slow or progressive increase of pulmonary arterial pressure (7, 21). Based on recent research findings, the traditional views of the pathogenesis of COPD patients with PH complications are questioned (2, 3). The traditional views believe that PH in COPD occurs as a consequence of alterations of the vasculature, such as vascular remodeling, associated with the emphysema and/or hypoxia. However, more and more evidence has shown that cigarette ingredients (such as nicotine) could directly affect the vessels and contribute to the occurrence of PH by generating a number of factors to regulate vascular contraction [i.e., endothelin-1 (ET-1)], vasodilation [i.e., endothelial nitric oxide synthase (eNOS)], vascular cell proliferation [i.e., ET-1 and vascular endothelial growth factor (VEGF)] and eventually lead to vascular remodeling and physiological responses (11, 22, 25, 33, 35–39). Research showed that CS-induced PH was essentially associated with inducible nitric oxide synthase (iNOS) and that targeting iNOS by pharmacological inhibition could improve the functional and structural abnormalities caused by CS (23). In addition, increased expression of vasoactive substances such as VEGF and ET-1 have been found in guinea pig models of chronic CS exposure, which as reported, is closely related to vascular proliferation and increased pulmonary arterial pressure (38).
Canonical transient receptor potential (TRPC) channels belong to the cation channel superfamily located on the plasma membrane, which have been well defined as playing essential roles during the PH disease process through multiple mechanisms. Previously, Feng et al. (4) found that mutant worms lacking TRPC channels were defective in their response to nicotine and such a defect could be rescued by a human TRPC channel, which revealed an unexpected role of TRPC channels in regulating nicotine-dependent behavior. We and others have previously confirmed that the proteins encoded by TRPC genes are components of the store-operated calcium channel (SOCC) and receptor-operated calcium channel (ROCC) (10, 31). During PH pathophysiological progress, enhanced Ca2+ influx through SOCC, termed store-operated calcium entry (SOCE), results in elevated intracellular calcium concentration ([Ca2+]i) and subsequently promotes PASMCs migration and proliferation, leading to hypertrophy of PASMCs and increase of pulmonary vascular tone (32, 40, 41). Excessive migration and proliferation of PASMCs are thought to be the main reasons for pulmonary media thickness and vascular remodeling.
Based on this background, we sought to clarify whether chronic CS exposure contributes to PH development by regulating TRPC expressions and [Ca2+]i in PASMCs, which are closely related to increased contractile activity and remodeling of pulmonary vessels. This study focused on investigating the effects of chronic CS exposure on TRPC1 and TRPC6 expression and SOCE in rat models of chronic CS exposure, as well as the effects of nicotine (10 nM) on [Ca2+]i and TRPC expressions in cultured rat distal PASMCs to elucidate the potential mechanisms of CS-induced pulmonary hypertension.
MATERIALS AND METHODS
Chronic CS exposure rat model establishment.
All procedures were approved by the Animal Care and Use Committee of Guangzhou Medical University. Adult SPF male Sprague-Dawley (SD) rats (250∼300 g, provided by Experimental Animal Center of Guangdong Province) were put in a 60 × 57 × 100 cm fume box (the oxygen concentration inside was 20 -20.8%) and systemically exposed to 16 filter-tipped cigarettes (Red Roses from Guangdong Cigarette Factory. The amount of tar was 13 mg; nicotine quantity was 1.3 mg; and carbon monoxide in flue gas was 15 mg) twice a day, 6 days per wk. Each exposure lasted for 1 h, and the interval between two exposures was at least 4 h; the rats were randomly grouped as control and chronic CS exposure for 1, 3, and 6 mo, respectively. The control groups were housed in a smoke-free environment.
Hemodynamic measurements and lung histochemistry.
Right ventricular pressure and right ventricular hypertrophy were measured using the same method as we described previously (12). Briefly, a 23-gauge needle filled with heparinized saline was connected to a pressure transducer and inserted via the diaphragm into the right ventricle. The right ventricular systolic pressure (RVSP) and mean pulmonary arterial pressure (mPAP) were then recorded and measured. Right ventricular hypertrophy was evaluated as the wet weight ratio of right ventricle to left ventricle (RV/LV) with septum (S) and right ventricle to body weight. To visualize intrapulmonary vessels, hematoxylin and eosin staining was performed on formalin-fixed and paraffin-embedded lung cross sections (5 μm). Vascular parameters in hematoxylin and eosin stained slides were measured with Image-Pro Plus 6.0 software by two independent operators in a masked manner. For immunofluorescence staining, we used the primary monoclonal antibodies raised against smooth muscle α-actin (Sigma) and factor VIII (Boster), FITC-conjugated (excitation λ = 488 nm), and CY3-conjugated secondary antibodies (excitation λ = 543 nm). Slides were observed under a laser-scanning confocal fluorescence microscope (Nikon, Japan).
Distal pulmonary arteries isolation and PASMCs culture.
Rat distal pulmonary arteries (>4th generations) denuded from adventitia and endothelium were isolated from anesthetized male SD rats as previously described (14, 32). PASMCs were enzymatically dissociated from tissue, harvested, and cultured with Smooth Muscle Growth Medium (SmGM-2; Clonetics) containing 5% FBS. Cells grew to about 60∼70% confluence, were serum starved for 24 h in Smooth Muscle Basal Medium (SmBM; Clonetics) containing 0.3% FBS, and subjected to nicotine treatment (10 nM, 24 h).
Intracellular Ca2+ determination.
Basal [Ca2+]i and SOCE were measured in PASMCs using fura-2 dye and fluorescent microscopy. Coverslips with myocytes were incubated with 7.5 μmol/l fura-2 AM (Invitrogin, NY) for 60 min at 37°C under an atmosphere of 5% CO2-95% air, mounted in a closed polycarbonate chamber clamped in a heated aluminum platform (PH-2; Warner Instrument, Hamden, CT) on the stage of a Nikon TSE 100 Ellipse inverted microscope (Nikon, Melville, NY), and perfused at 0.5 ml/min with Krebs Ringer bicarbonate solution that contained the following (in mM): 118 NaCl, 4.7 KCl, 2.5 CaCl2, 0.57 MgSO4, 1.18 KH2PO4, 25 NaHCO3, and 10 glucose. Perfusate was equilibrated with 5% CO2 and the desired O2 concentration in heated reservoirs and led to the chamber through stainless steel tubing. Chamber temperature was maintained at 37°C with an in-line heat exchanger and dual channel heater controller (SF-28 and TC-344B; Warner Instruments). After perfusion for 10 min to remove extracellular dye, we measured fura-2 fluorescence emitted at 510 nm after excitation at 340 and 380 nm (F340, F380) in 15∼30 cells using a xenon arc lamp, interference filters, electronic shutter, ×20 fluorescence objective, and cooled charge-coupled device imaging camera, as previously described (12). Protocols were executed and data were collected on-line with InCyte software (Intracellular Imaging, Cincinnati, OH). Fura-2 fluorescence ratios (R = F340/F380) allowed estimation of [Ca2+]i from R measured in calibration solutions with [Ca2+] between 0 and 1,350 nM (Molecular Probes). We first measured [Ca2+]i at 12 s intervals before and after the restoration of extracellular [Ca2+]i to 2.5 mM. SOCE was evaluated from the increase in [Ca2+]i caused by restoration of extracellular [Ca2+]i in the continued presence of nifedipine and cyclopiazonic acid (CPA).
Quantitative RT-PCR.
Total RNA in distal pulmonary arteries or PASMCs was extracted using Trizol (Invitrogen). mRNA was reverse transcribed in a reaction mixture of 20 μl containing 1,000 ng total RNA using iScript cDNA synthesis kit (Takara Biotechnology), followed by quantification with real-time PCR using Scofast EvaGreen superMix (Bio-Rad, Hercules, CA). The PCR reaction mixture of 25 μl was composed of 400 nM forward and reverse primers and cDNA template from 6.25 ng RNA. The program of real-time quantitative PCR consisted of a hot start at 95°C for 15 min, 45 cycles with each containing 94°C for 15 s, 57.5°C for 20 s and 72°C for 20 s, and melting curves performed at 95°C for 1 min, 55°C for 1 min, and an increment of 0.5°C for 80 repeats. Specificity of the PCR products was sequentially verified by melting curves, agarose gel electrophoresis, and DNA sequencing. Detection threshold cycle (CT) values were generated by iCyclerIQ software. PCR efficiency of each pair of primers was obtained from measurements of five-point serial dilutions of an unknown cDNA sample. The relative concentration of each transcript was calculated using the Pfaffl method. mRNA copies were normalized and were expressed as percent change from control values. The primers were synthesized by TAKARA Biotechnology, and the sequences are listed in Table 1.
Table 1.
Real-time PCR primers
| Primer Name | Primer Sequence |
|---|---|
| TRPC1-F | 5′-AGCCTCTTGACAAACGAGGA-3′ |
| TRPC1-R | 5′-ACCTGACATCTGTCCGAACC-3′ |
| TRPC6-F | 5′-TACTGGTGTGCTCCTTGCAG-3′ |
| TRPC6-R | 5′-GAGCTTGGTGCCTTCAAATC-3′ |
| β-Actin-F | 5′-ACGGTCAGGTCATCACTATC-3′ |
| β-Actin-R | 5′-TGCCACAGGATTCCATACC-3′ |
TRPC, canonical transient receptor potential; F, forward; R, reverse.
Western blot analysis.
The rat distal pulmonary artery was sonicated in RIPA lysis buffer (Bocai Biological) with protease inhibitor cocktail tablet, and protein expression was measured by immunoblotting assay as described previously. Protein lysate was quantified using the bicinchoninic acid protein assay (Pierce, Rockford, IL). Protein lysate was then denatured by adding dithiothreitol to 150 mM and heating at 95°C for 3 min and resolved by 10% SDS-PAGE. Separated proteins were transferred onto polyvinylidene difluoride membranes (pore size 0.45 μM; Bio-Rad). Membranes were blocked with 5% nonfat dry milk in Tris-buffered saline containing 0.2% Tween 20 and blotted with affinity-purified rabbit polyclonal antibodies specific for TRPC1 (Santa Cruz Biotechnology, Santa Cruz, CA), and TRPC6 (Alomone) proteins or mouse monoclonal antibodies to α-actin (Sigma, St. Louis, MO). Bound antibodies were probed with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (Kirkegaard and Perry Laboratories, Gaithersburg, MD) and detected using an enhanced ECL chemiluminescence system.
Statistical analysis.
The statistical software SPSS 13.0 was used for analysis; data are represented as means ± SE. The body weight was analyzed using the Kruskal-Wallis test followed by the Mann-Whitney U-test with Bonferroni correction and others were analyzed using ANOVA and Student's t-test. The pairwise comparison of means was conducted with Student's t-test, if statistically significant F-ratios were obtained with the ANOVA analysis. “n” Equals the number of animals from which pulmonary arteries or cells were obtained. Differences were considered significant when P < 0.05 (*significant difference from control group, P < 0.05; **significant difference from control group, P < 0.01).
RESULTS
Effects of chronic CS exposure on changes in body weight of rats.
Throughout the whole exposure process, there was no death in the CS exposure group or the control group. Rats under CS for 1, 3, and 6 mo weighed 383 ± 59, 409 ± 59, and 476 ± 84 g, weights that were significantly lower than those in each respective control group, which were 414 ± 60, 510 ± 70, and 640 ± 82 g (P < 0.01). As shown in Fig. 1, the difference in body weight between the CS exposure group and control group became more apparent following the CS exposing time course.
Fig. 1.
Effects of chronic exposure to cigarette smoke (CS) on rats' weight at different time points (means ± SE; n = 10). Line chart shows the changes in body weight of rats exposed to chronic CS or control air. Time course shows from 0 wk up to 30 wk. *P < 0.05, significant difference from CS group; **P < 0.01, significant difference from CS group.
Effects of chronic CS exposure on RVSP, mPAP, and right ventricular hypertrophy in rats.
As shown in Fig. 2, A and B, CS exposure for 1 mo and 3 mo had no significant effect on mPAP and RVSP between CS exposure and control groups. However, the mPAP in the 6-mo CS exposure group was significantly higher than that in the control (13.01 ± 0.74 vs. 9.56 ± 0.33 mmHg, P < 0.01). Also, the RVSP in the 6-mo CS exposure group was significantly elevated compared with control (29.73 ± 0.83 vs. 23.12 ± 0.837 mmHg, P < 0.01). As shown in Fig. 2C, compared with the control groups, RV/(LV + S) in the 6-mo CS exposure rats was significantly increased from 0.25 ± 0.03 to 0.31 ± 0.01 (P < 0.01), whereas in CS exposure groups for 1 and 3 mo, no significant right ventricular hypertrophy was found. These changes indicated that after 6-mo smoke exposure, the right ventricular hypertrophy was developed.
Fig. 2.
Effects of chronic exposure to CS on rats' vascular pressure and index of right ventricular hypertrophy (means ± SE; n = 4∼6). A: mean pressure of right ventricle (mPAP). B: right ventricular systolic pressure (RVSP). C: index of right ventricular hypertrophy [RV/(LV+S)]. *P < 0.05, significant difference from control group.
Effects of chronic CS exposure on pulmonary arterial remodeling.
As shown in Fig. 3, the intima of small pulmonary arteries in rats of control groups was complete and smooth, no muscle layer thickening, and no inflammatory cell infiltration (Fig. 3, A, C, and E); In the group of 1-mo CS exposure, there were scattered inflammatory cell infiltration in the alveolar septa; the pulmonary arterial wall was not thickened compared with the control group (Fig. 3B). In group of CS exposure for 3 mo, the pulmonary arterial wall and the smooth muscle layer were observed to be thickened. Additionally, stenosis and perivascular inflammatory cell infiltration were also found (Fig. 3D). The inflammatory cell infiltration was more obvious in the 6-mo CS exposure group, in which there were marked diameter stenosis and thickening of pulmonary arterial wall (Fig. 3F). The ratio of vascular lumen area (2 × medial wall thickness/external diameter) in CS-exposed rats (average 51.94 ± 1.87%) was statistically greater than that in normal controls (average: 39.58 ± 4.23%, P = 0.001, Fig. 3G). To confirm the cell types involved in the remodeling process, endothelial cells and PASMCs on the pathological slides were labeled with anti-rat VIII factor in red and anti-rat α-actin in green (Fig. 3, H and I). There was marked diameter stenosis and thickening of smooth muscle layer in the 6-mo CS-exposed rat compared with normal control. Thickening in vascular endothelium was not detected. These results suggest that PASMCs do more direct contributions to the remodeling process than endothelial cells.
Fig. 3.

Effects of chronic exposure to CS on pulmonary vascular remodeling in rats (×200). Lung tissues from rats under control or chronic exposure to CS for 1, 3, and 6 mo were fixed in 4% paraformaldehyde, embedded in paraffin, cross sectioned, and stained with hematoxylin and eosin (H&E staining), as shown in A, C, and E. The results are representative from 1 of 4 rats for each group. The experiment was repeated for 3 times. B, D, and F: pulmonary artery wall thickening induced by cigarette smoke exposure, compared with the control group. Arrows indicate pulmonary artery in each picture. G: difference of vascular lumen area ratio in CS-exposed rats and controls (means ± SE; n = 4). Immunostaining was performed to label the endothelial cell in red and pulmonary arterial smooth muscle cells (PASMCs) in green on the slides. Smooth muscle layer was much thickening and vascular inner diameter was dramatically stenosed in CS-exposed group. H and I: representative visual fields from normal control and CS-exposed rats.
Effects of chronic exposure to CS on the SOCE and basal [Ca2 +]i in freshly isolated rat distal PASMCs.
As shown in Fig. 4, A and B, there was no difference in SOCE between 1-mo CS exposure group and the control group; SOCE in 3-mo CS exposure group was 240.68 ± 51.49 and 151.09 ± 10.89 nM in the control group, and these results had statistical difference (P < 0.05); SOCE in 6-mo CS exposure group was 272.34 ± 47.62 nM, also significantly higher than that of the control group which was 180.19 ± 18.30 nM (P < 0.01). As shown in Fig. 4C, there was no significant difference in the basal [Ca2+]i between 1-mo CS exposure group and the control group. The basal [Ca2+]i in 3-mo CS exposure group was statistically higher than that in the control group (127.88 ± 12.67 vs. 107.06 ± 2.12 nM, P < 0.05). In 6-mo CS exposure group, the basal [Ca2+]i was further elevated and exhibited significant difference compared with the control group (180.77 ± 15.17 vs. 127.65 ± 24.97 nM, P < 0.01).
Fig. 4.
Effects of chronic exposure to CS on basal intracellular calcium concentration ([Ca2+]i) and store-operated calcium entry (SOCE) in PASMCs of rats. A and B: changes of SOCE in PASMCs isolated from control group and CS group (means ± SE; n = 4). *P < 0.05, significant difference from control group. **P < 0.01, significant difference from control group. C: changes of basal [Ca2+]i in PASMCs isolated from control group and CS group (means ± SE; n = 4). The measure of the SOCE reported corresponds to the peak of the SOCE response. *P < 0.05, significant difference from control group. **P < 0.01, significant difference from control group.
Effects of chronic CS exposure on TRPC1 and TRPC6 mRNA and protein expression in rat distal pulmonary artery smooth muscle.
As shown in Fig. 5, A and B, the CS exposure significantly promoted TRPC1 and TRPC6 mRNA expression in rat distal pulmonary artery smooth muscle, which showed a persistent increase. The most apparent upregulation occurs under 1-mo CS exposure compared with the control group, and the trend of increase slowed down in 3- and 6-mo CS exposure groups. However, significant increases were observed under all the three time points (P < 0.01). Figure 5, C-E, shows the effects of chronic CS exposure on TRPC1 and TRPC6 protein expression. Similarly, compared with control groups, such exposure also significantly increased TRPC1 and TRPC6 protein expression in rat pulmonary artery smooth muscle under all the three different time points (chronic CS exposure for 1, 3, and 6 mo, P < 0.01).
Fig. 5.
Effects of chronic cigarette smoke exposure on canonical transient receptor potential 1 (TRPC1) and TRPC6 mRNA and protein expression in rat distal pulmonary artery smooth muscle. TRPC1 (A) and TRPC6 (B) mRNA relative to β-actin was measured by real-time quantitative PCR. Expression levels of TRPC1 and TRPC6 proteins were detected by Western blotting (C–E). Representative blots (C) and mean intensity for TRPC1 (D) or TRPC6 (E) blots relative to α-actin. Bar values are means ± SE (n = 4 in each group). *P < 0.05, significant difference from respective control group. **P < 0.01, significant difference from control group.
Effects of nicotine stimulation on the intracellular Ca2+ homeostasis in cultured rat distal PASMCs.
To distinguish between a direct effect of CS exposure on intracellular Ca2+ homeostasis and the effects of circulating factors change during chronic CS exposure, we isolated the rat distal PASMCs, after appropriate culture in growth medium (3∼4 days, 60∼70% cell density) and starving (0.3% FBS, 24 h), cells were incubated with the main component of cigarette, nicotine (10 nM, 24 h), and PASMCs without treatment served as control. Results showed that basal [Ca2+]i in the nicotine stimulated PASMCs was 136.5 ± 9.98 nM, significantly higher than that of control cells (97.67 ± 5.03 nM; Fig. 6 A, P < 0.01). SOCE in nicotine-stimulated cells was 315.7 ± 37.33 nM, significantly increased compared with that in control cells at 200.7 ± 17.23 nM as shown in Fig. 6, B and C (P < 0.05).
Fig. 6.
Effects of nicotine treatment (10 nM, 24 h) on the intracellular Ca2+ homeostasis in cultured rat distal PASMCs. A: basal [Ca2+]i in control and nicotine-treated PASMCs (means ± SE; n = 4). *P < 0.05, significant difference from control group. B and C: changes of SOCE in control and nicotine-treated PASMCs (means ± SE; n = 4). *P < 0.05, significant difference from control group.
Effects of nicotine stimulation on TRPC1 and TRPC6 expression in cultured rat distal PASMCs.
In nicotine (10 nM, 24 h)-treated PASMCs, mRNA expression of TRPC1 and TRPC6 (Fig. 7A) as detected by real-time PCR was significantly increased compared with that in untreated control cells. Similarly, Western blotting analysis demonstrated that the protein levels of TRPC1 and TRPC6 (Fig. 7, B and C) were also upregulated in nicotine-treated PASMCs compared with those in untreated cells.
Fig. 7.
Effects of nicotine treatment (10 nM, 24 h) on TRPC1 and TRPC6 mRNA and protein expression in cultured rat distal PASMCs. A: effects of nicotine stimulation on TRPC1 and TRPC6 mRNA expression in control and nicotine treated PASMCs (means ± SE; n = 4). *P < 0.05, significantly different from control group. B: representative immunoblot images showing TRPC1 and TRPC6 protein expression in control and nicotine-treated PASMCs. C: bar graph showing means ± SE values in TRPC1 and TRPC6 protein expression in control and nicotine treated PASMCs (means ± SE; n = 4). *P < 0.05, significantly different from control group.
Effects of TRPC1 and TRPC6 knockdown on nicotine-induced increase of basal [Ca2+]i in rat distal PASMCs.
Specific siRNA against TRPC1 (siTRPC1) and TRPC6 (siTRPC6) were synthesized, and nontargeted siRNA (siNT) was used as a control. To measure the effects of siTRPC1, 6 on nicotine upregulated TRPCs expression, cells were divided into four groups: siNT + control, siNT + nicotine, siTRPC1 + nicotine, and siTRPC6 + nicotine. siRNAs transfected cells were incubated with or without 10 nM nicotine for 24 h. The specificity and knockdown efficiency of siTRPC1 and siTRPC6 were detected using Western blotting. As shown in Fig. 8, A and B, siTRPC1 effectively reduced TRPC1 protein expression without altering TRPC6; similarly, TRPC6 expression was downregulated by siTRPC6 without significant alteration of TRPC1. Nicotine treatment increased basal [Ca2+]i (135.47 ± 3.33 nM in siNT + nicotine group vs. 108.38 ± 2.42 nM in siNT + control group, P < 0.001) in PASMCs and this increase was significantly reduced after siTRPC1 and siTRPC6 treatment (117.65 ± 3.29 nM in siTRPC1 + nicotine group, and 118.67 ± 3.97 nM in siTRPC6 + nicotine group; P < 0.05 each comparing to siNT+nicotine. Fig. 8E). Consistent with the results of basal [Ca2+]i, SOCE measurement revealed that nicotine treatment enhanced the SOCE (440.43 ± 20.67 nM in siNT + nicotine group, P < 0.001) from baseline (187.66 ± 28.16 nM in siNT + control group). This enhancement was reduced when treated with either siTRPC1 (269.02 ± 15.29 nM in siTRPC1 + nicotine group, P < 0.001) or siTRPC6 (287.12 ± 11.01 nM in siTRPC6 + nicotine group, P < 0.001, Fig. 8, C and D). These results indicate that the nicotine-induced increases of basal [Ca2+]i and SOCE in PASMC are TRPC dependent.
Fig. 8.
Effects of siTRPC1 and siTRPC6 on basal [Ca2+]i in nicotine-treated rat distal PASMCs. A: Western blot showing expression of TRPC1, TRPC6, and α-actin protein in nicotine, siNT. and siTRPC-treated PASMCs. B: bar graph showing means ± SE values (n = 3) in TRPC1 and TRPC6 protein expression relative to siNT control. *P < 0.05, significantly different from siNT control group. §P < 0.05, significantly different from siNT + nicotine group. C: trace graph shows [Ca2+]i change (Δ[Ca2+]i) before and after restoration of extracellular [Ca2+]i to 2.5 mM in PASMCs perfused with Ca2+-free Krebs ringer bicarbonate solution in each group. CPA, cyclopiazonic acid. D: average peak [Ca2+]i obtained from cells shown in C (means ± SE; n = 4). *P < 0.01, significantly different from control group. §P < 0.01, significantly different from siNT + nicotine group. E: basal [Ca2+]i in each group of PASMCs (means ± SE; n = 4). *P < 0.01 versus control group. §P < 0.01 versus siNT + nicotine group.
DISCUSSION
In this study, we demonstrated that chronic exposure to CS led to rat weight loss, right ventricular hypertrophy, and pulmonary arterial remodeling. For the in vivo study, chronic CS exposure for 3 and 6 mo significantly increased basal [Ca2+]i and SOCE levels in freshly isolated rat distal PASMCs. In association with these changes, the expression of TRPC1 and TRPC6 in rat distal PA was also found to be upregulated, suggesting the CS exposure elevated [Ca2+]i is at least in part due to increased SOCE and SOCC components. Moreover, we demonstrated that nicotine treatment was also able to induce increased basal [Ca2+]i and SOCE, as well as increased TRPC1 and TRPC6 expression in rat distal PASMCs.
Tobacco smoke, when burned, releases over 4,700 chemicals, and the main harmful components include carbon monoxide, nicotine, amines, nitriles, alcohols, phenols, alkanes, alkenes, carbonyl compounds, nitrogen oxides, polycyclic aromatic hydrocarbons, heterocyclic compounds, heavy metals, organic pesticides etc. Among these components, nicotine and its metabolites attract our attention because of their ability to stimulate PASMC proliferation, causing pulmonary artery medial hypertrophy, vascular remodeling, and luminal narrowing of blood vessels, which is thought to be a main reason resulting in PH. Wright and Churg (34) reported that the pulmonary arterial pressure of guinea pigs was increased after 6-mo exposure to CS and also the muscularization of pulmonary arteriole was enhanced. Similarly, Han et al. (6) found that CS exposure for 6 mo significantly thickened pulmonary artery medial wall and increased the RVSP in rats. Consistent with previous reports, our results in this study indicated that chronic CS exposure could induce rat pulmonary arterial wall thickness; sustained pulmonary artery thickness then leads to increase in RVSP. As a result, right ventricular hypertrophy may occur. In conclusion, chronic CS has, at least indirectly or partially affect the right ventricle. After 3-mo CS exposure, the pulmonary arterial wall of rats started thickening, the longer the exposure was, the more obvious the trend was; yet, the RVSP and mean PAP were not increased until 6-mo smoke exposure.
In the rat and mouse animal models, chronic hypoxia can lead to chronic hypoxic pulmonary hypertension. We along with other groups have confirmed that chronic hypoxia contributes to the increase of [Ca2+]i in PASMCs, mainly caused by enhanced SOCE through SOCC (26). To demonstrate whether CS can affect SOCE in rat pulmonary arterial smooth muscle, the recovery of extracellular calcium was used. When voltage-dependent Ca2+ channel antagonist nifedipine was used to block the voltage-dependent Ca2+ channel activity, CPA rapidly elevated [Ca2+]i temporarily and slightly in PASMCs, suggested that calcium is released from sarcoplasmic reticulum. After the extracellular calcium concentration was recovered, CPA could make [Ca2+]i increased rapidly and maintained a high level; after the removal of CPA, [Ca2+]i returned back to the baseline level. In this process, we found that the [Ca2+]i in freshly isolated and short-term attached PASMCs from CS exposure rats can reach a higher marked level after recovery of extracellular calcium concentration than that in PASMCs from the control rats. These results suggest that chronic CS exposure could be an important trigger of enhanced SOCE and promote calcium influx in PASMCs.
The excitation-contraction coupling process in pulmonary vascular smooth muscle is known to be mainly dependent on the function of ion channels. The increase of [Ca2+]i is considered to play an essential role during the vasoconstriction and remodeling process. We linked such evidence to our previous theory about the relevant relationship among TRPC expression, intracellular calcium homeostasis, and the development of PH. It is reasonable to hypothesize that CS exposure-induced PH is potentially mediated via the regulation of the TRPC-SOCE-[Ca2+]i signaling cascade. SOCC is known to be mainly composed of the classical TRPC family members, among which TRPC1, TRPC4, and TRPC6 have been found to be the predominant one expressed in pulmonary artery smooth muscle of rat, mouse, and human (18, 19, 30–32). The upregulation of TRPC expression can increase the activity of SOCC, relating to enhanced SOCE, and also promotes the proliferation of PASMCs (5, 42). Additionally, upregulated TRPC1 and TRPC6 expression and elevated SOCE are also observed under chronic hypoxia in rat distal PASMCs (9, 32). In the present study, similar to the effects of chronic hypoxia, chronic exposure to CS promotes the [Ca2+]i and SOCE, as well as upregulated TRPC1 and TRPC6 expression in PASMCs. These results suggest that upregulation of TRPC1 and TRPC6 expression could be a key element attributable to the enhanced basal [Ca2+]i and SOCE activity during chronic CS exposure. Besides TRPCs, other Ca2+-related molecules such as STIM and Orai (13, 20), as well as the ability of the cells to maintain intracellular Ca2+ homeostasis depending on the mitochondrial function, ATP storage, and cell membrane permeability (8, 27), were also considered to be able to affect the intracellular calcium changes. It is, therefore, not surprising to note that TRPC proteins in rat distal PA were upregulated as early as 1-mo exposure to CS, whereas the changes in the Ca2+ level were not detectable until 3-mo exposure to CS. Further study is needed to elucidate the molecular mechanisms underlying the delayed calcium response following changes of TRPC1 and TRPC6 expression in PA smooth muscle.
Subsequently, additional experiments with nicotine treatment in vitro were performed to elucidate whether nicotine was responsible for the upregulation of TRPC1, TRPC6 expression, and the increases of [Ca2+]i and SOCE in PASMCs. Consistent with the results from chronically CS exposed rat, nicotine treatment (10 nM, 24 h) significantly increased the basal [Ca2+]i and SOCE levels in cultured rat distal PASMCs. TRPC1 and TRPC6 expression in PASMCs was observed to be upregulated by nicotine, and specific knockdown of TRPC1 and TRPC6 by siRNAs revealed that the nicotine-induced increases of basal [Ca2+]i and SOCE in PASMCs were TRPC dependent. In previous studies, nicotine has been proven to exert biological effects through binding to nicotinic acetylcholine receptors (nAChRs), which then induced activation of related signal transduction pathways, including Ca2+ influx and activation of calmodulin, protein kinase C, c-Src, and so on. nAChRs belong to the Pentamers formed by 12 kinds of subunits (α2–10 and β2–4) (28). Other studies have shown that there is a higher affinity and density of nicotinic acetylcholine receptors in the brain of smokers than nonsmokers (17). Intake of nicotine to pregnant rhesus monkeys made the α7-nAChR subunit expression levels increase in lung tissue of the fetus significantly and the maturation of the lung was also affected (24). Similar to mammals, nicotine can act on the nAChR of A Caenorhabditis elegans (a worm), leading to acute nicotine response, tolerance, withdrawal, and excitement and so on. However, mutant worms lack of TRPC channels are defective in their response to nicotine and such a defect can be rescued by a human TRPC channel. Therefore, it is likely that the alterations of TRPC and the basal [Ca2+]i and SOCE levels are nicotine dependent and might be the result of nAChR modulation on the surface of rat distal PASMCs. However, researchers recently demonstrated that a metabolic product of CS can change the epigenetic modifications of DNA, including promoter methylation profiles of critical genes involved in lung cancer (29). CS has also been found to affect the stability of noncoding RNAs (e.g., microRNA) that regulate message stability (15). Collectively, it cannot be excluded that CS exposure could cause changes in TRPC1 and TRPC6 expression directly at transcriptional or posttranscriptional level, or perhaps, via other pathways. Finally, the exact mechanism of long-term CS exposure-induced pulmonary vascular remodeling still is largely unknown and awaits further studies.
In conclusion, we found that chronic CS exposure could significantly promote TRPC1, TRPC6 mRNA, and protein expression and increase SOCE activity and basal [Ca2+]i in PASMCs. In vitro experiments suggested that the effects of nicotine on TRPC expression and intracellular calcium homeostasis of distal PASMCs likely play an indispensable role during the development of CS-induced PH.
GRANTS
This work was supported by National Heart, Lung, and Blood Institute Research Grant R01-HL-093020; National Natural Science Foundation of China Grants 81070043, 81071917, 81173112, 81170052, 81200038, 81300016, and 81220108001; Guangdong Department of Science and Technology of China Grants 2009B050700041 and 2010B03160030; Guangdong Department of Education Research Grant cxzd1025; Guangdong Natural Science Foundation Team Grant (2010); and Guangzhou Department of Education Yangcheng Scholarship (10A058S, 12A001S).
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the author(s).
AUTHOR CONTRIBUTIONS
Author contributions: W.L., J.W., L.Z., N.S.Z., and P.R. conception and design of research; W.L., J.W., Y.C., C.L., J.J., K.Y., L.Z., N.L., and Q.J. analyzed data; J.W., Y.C., C.L., J.J., L.Z., and W.L. interpreted results of experiments; J.W., Y.C., C.L., J.J., L.T., K.Y., N.L., and W.L. prepared figures; J.W., Y.C., C.L., L.T., K.Y., N.L., and W.L. drafted manuscript; J.W., L.T., Y.S., N.S.Z., P.R., and W.L. edited and revised manuscript; W.L. and J.W. approved final version of manuscript; Y.C., C.L., J.J., L.Z., and Q.J. performed experiments.
REFERENCES
- 1.Chaouat A, Gomez E, Canuet M, Weitzenblum E, Chabot F. [Clinical classification and epidemiology of pulmonary arterial hypertension]. Rev Prat 58: 1991–1996, 2008 [PubMed] [Google Scholar]
- 2.Doi M, Nakano K, Hiramoto T, Kohno N. Significance of pulmonary artery pressure in emphysema patients with mild-to-moderate hypoxemia. Respir Med 97: 915–920, 2003 [DOI] [PubMed] [Google Scholar]
- 3.Falk JA, Martin UJ, Scharf S, Criner GJ. Lung elastic recoil does not correlate with pulmonary hemodynamics in severe emphysema. Chest 132: 1476–1484, 2007 [DOI] [PubMed] [Google Scholar]
- 4.Feng Z, Li W, Ward A, Piggott BJ, Larkspur ER, Sternberg PW, Xu XZ. elegans model of nicotine-dependent behavior: regulation by TRP-family channels. Cell 127: 621–633, 2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Golovina VA, Platoshyn O, Bailey CL, Wang J, Limsuwan A, Sweeney M, Rubin LJ, Yuan JX. Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 280: H746–H755, 2001 [DOI] [PubMed] [Google Scholar]
- 6.Han SX, He GM, Wang T, Chen L, Ning YY, Luo F, An J, Yang T, Dong JJ, Liao ZL, Xu D, Wen FQ. Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2. Toxicol Appl Pharmacol 245: 100–107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kessler R, Faller M, Weitzenblum E, Chaouat A, Aykut A, Ducolone A, Ehrhart M, Oswald-Mammosser M. “Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 164: 219–224, 2001 [DOI] [PubMed] [Google Scholar]
- 8.Kiselyov K, Muallem S. Mitochondrial Ca2+ homeostasis in lysosomal storage diseases. Cell Calcium 44: 103–111, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lin MJ, Leung GP, Zhang WM, Yang XR, Yip KP, Tse CM, Sham JS. Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ Res 95: 496–505, 2004 [DOI] [PubMed] [Google Scholar]
- 10.Liu XR, Zhang MF, Yang N, Liu Q, Wang RX, Cao YN, Yang XR, Sham JS, Lin MJ. Enhanced store-operated Ca2+ entry and TRPC channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Cell Physiol 302: C77–C87, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Louzier V, Raffestin B, Leroux A, Branellec D, Caillaud JM, Levame M, Eddahibi S, Adnot S. Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 284: L926–L937, 2003 [DOI] [PubMed] [Google Scholar]
- 12.Lu W, Ran P, Zhang D, Peng G, Li B, Zhong N, Wang J. Sildenafil inhibits chronically hypoxic upregulation of canonical transient receptor potential expression in rat pulmonary arterial smooth muscle. Am J Physiol Cell Physiol 298: C114–C123, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lu W, Wang J, Peng G, Shimoda LA, Sylvester JT. Knockdown of stromal interaction molecule 1 attenuates store-operated Ca2+ entry and Ca2+ responses to acute hypoxia in pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol 297: L17–L25, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lu W, Wang J, Shimoda LA, Sylvester JT. Differences in STIM1 and TRPC expression in proximal and distal pulmonary arterial smooth muscle are associated with differences in Ca2+ responses to hypoxia. Am J Physiol Lung Cell Mol Physiol 295: L104–L113, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Maccani MA, Knopik VS. Cigarette smoke exposure-associated alterations to non-coding RNA. Front Genet 3: 53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 137: 39S-51S [DOI] [PubMed] [Google Scholar]
- 17.Mukhin AG, Kimes AS, Chefer SI, Matochik JA, Contoreggi CS, Horti AG, Vaupel DB, Pavlova O, Stein EA. Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2–18F-FA-85380. J Nucl Med 49: 1628–1635, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ng LC, Gurney AM. Store-operated channels mediate Ca(2+) influx and contraction in rat pulmonary artery. Circ Res 89: 923–929, 2001 [DOI] [PubMed] [Google Scholar]
- 19.Ng LC, McCormack MD, Airey JA, Singer CA, Keller PS, Shen XM, Hume JR. TRPC1 and STIM1 mediate capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells. J Physiol 587: 2429–2442, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ng LC, Ramduny D, Airey JA, Singer CA, Keller PS, Shen XM, Tian H, Valencik M, Hume JR. Orai1 interacts with STIM1 and mediates capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol 299: C1079–C1090, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 166: 314–322, 2002 [DOI] [PubMed] [Google Scholar]
- 22.Schermuly RT, Kreisselmeier KP, Ghofrani HA, Yilmaz H, Butrous G, Ermert L, Ermert M, Weissmann N, Rose F, Guenther A, Walmrath D, Seeger W, Grimminger F. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Am J Respir Crit Care Med 169: 39–45, 2004 [DOI] [PubMed] [Google Scholar]
- 23.Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, Weisel FC, Milger K, Egemnazarov B, Turowska A, Fuchs B, Nikam S, Roth M, Sydykov A, Medebach T, Klepetko W, Jaksch P, Dumitrascu R, Garn H, Voswinckel R, Kostin S, Seeger W, Schermuly RT, Grimminger F, Ghofrani HA, Weissmann N. Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell 147: 293–305 [DOI] [PubMed] [Google Scholar]
- 24.Sekhon HS, Jia Y, Raab R, Kuryatov A, Pankow JF, Whitsett JA, Lindstrom J, Spindel ER. Prenatal nicotine increases pulmonary alpha7 nicotinic receptor expression and alters fetal lung development in monkeys. J Clin Invest 103: 637–647, 1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Shimoda LA, Sham JS, Liu Q, Sylvester JT. Acute and chronic hypoxic pulmonary vasoconstriction: a central role for endothelin-1? Respir Physiol Neurobiol 132: 93–106, 2002 [DOI] [PubMed] [Google Scholar]
- 26.Sylvester JT, Shimoda LA, Aaronson PI, Ward JP. Hypoxic pulmonary vasoconstriction. Physiol Rev 92: 367–520 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Takekawa M, Furuno T, Hirashima N, Nakanishi M. Mitochondria take up Ca2+ in two steps dependently on store-operated Ca2+ entry in mast cells. Biol Pharm Bull 35: 1354–1360 [DOI] [PubMed] [Google Scholar]
- 28.Unwin N. Refined structure of the nicotinic acetylcholine receptor at 4A resolution. J Mol Biol 346: 967–989, 2005 [DOI] [PubMed] [Google Scholar]
- 29.Vuillemenot BR, Hutt JA, Belinsky SA. Gene promoter hypermethylation in mouse lung tumors. Mol Cancer Res 4: 267–273, 2006 [DOI] [PubMed] [Google Scholar]
- 30.Wang C, Wang J, Zhao L, Wang Y, Liu J, Shi L, Xu M. Sildenafil inhibits human pulmonary artery smooth muscle cell proliferation by decreasing capacitative Ca2+ entry. J Pharm Sci 108: 71–78, 2008 [DOI] [PubMed] [Google Scholar]
- 31.Wang J, Shimoda LA, Sylvester JT. Capacitative calcium entry and TRPC channel proteins are expressed in rat distal pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol 286: L848–L858, 2004 [DOI] [PubMed] [Google Scholar]
- 32.Wang J, Weigand L, Lu W, Sylvester JT, Semenza GL, Shimoda LA. Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells. Circ Res 98: 1528–1537, 2006 [DOI] [PubMed] [Google Scholar]
- 33.Wright JL. Relationship of pulmonary arterial pressure and airflow obstruction to emphysema. J Appl Physiol 74: 1320–1324, 1993 [DOI] [PubMed] [Google Scholar]
- 34.Wright JL, Churg A. Effect of long-term cigarette smoke exposure on pulmonary vascular structure and function in the guinea pig. Exp Lung Res 17: 997–1009, 1991 [DOI] [PubMed] [Google Scholar]
- 35.Wright JL, Dai J, Zay K, Price K, Gilks CB, Churg A. Effects of cigarette smoke on nitric oxide synthase expression in the rat lung. Lab Invest 79: 975–983, 1999 [PubMed] [Google Scholar]
- 36.Wright JL, Lawson L, Pare PD, Hooper RO, Peretz DI, Nelems JM, Schulzer M, Hogg JC. The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise. Am Rev Respir Dis 128: 702–707, 1983 [DOI] [PubMed] [Google Scholar]
- 37.Wright JL, Tai H, Churg A. Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries. Am J Respir Cell Mol Biol 31: 501–509, 2004 [DOI] [PubMed] [Google Scholar]
- 38.Wright JL, Tai H, Churg A. Vasoactive mediators and pulmonary hypertension after cigarette smoke exposure in the guinea pig. J Appl Physiol 100: 672–678, 2006 [DOI] [PubMed] [Google Scholar]
- 39.Wright JL, Tai H, Dai J, Churg A. Cigarette smoke induces rapid changes in gene expression in pulmonary arteries. Lab Invest 82: 1391–1398, 2002 [DOI] [PubMed] [Google Scholar]
- 40.Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, Platoshyn O, Tigno DD, Thistlethwaite PA, Rubin LJ, Yuan JX. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc Natl Acad Sci USA 101: 13861–13866, 2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, Yuan JX. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol 284: C316–C330, 2003 [DOI] [PubMed] [Google Scholar]
- 42.Yuan XJ, Wang J, Juhaszova M, Gaine SP, Rubin LJ. Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet 351: 726–727, 1998 [DOI] [PubMed] [Google Scholar]







